► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

British pharmaceutical company AstraZeneca buys out venture partner Bristol-Myers Squibb from diabetes drug alliance, ticking two growth priorities - diabetes and growth in emerging markets. Lex's Joseph Cotterill and Vincent Boland discuss the developments.

For more video content from the Financial Times, visit http://www.FT.com/video

Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes